vs
DIGI INTERNATIONAL INC（DGII）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是DIGI INTERNATIONAL INC的1.8倍（$219.9M vs $122.5M），DIGI INTERNATIONAL INC净利率更高（9.6% vs -1.0%，领先10.6%），DIGI INTERNATIONAL INC同比增速更快（17.9% vs 2.0%），DIGI INTERNATIONAL INC自由现金流更多（$35.2M vs $16.8M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs 6.6%）
Digi International Inc.是总部位于美国明尼苏达州霍普金斯的工业物联网（IIoT）科技企业，成立于1985年。上世纪90年代初，该公司以生产多线路串行数据卡闻名，可支持兼容机运行多线路公告板系统（BBS）。90年代末互联网兴起后，公司逐步转向网络接入设备与工业监测领域布局。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
DGII vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.8倍
$122.5M
营收增速更快
DGII
高出15.9%
2.0%
净利率更高
DGII
高出10.6%
-1.0%
自由现金流更多
DGII
多$18.3M
$16.8M
两年增速更快
OFIX
近两年复合增速
6.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $122.5M | $219.9M |
| 净利润 | $11.7M | $-2.2M |
| 毛利率 | 62.4% | 71.1% |
| 营业利润率 | 13.3% | 0.2% |
| 净利率 | 9.6% | -1.0% |
| 营收同比 | 17.9% | 2.0% |
| 净利润同比 | 16.1% | 92.4% |
| 每股收益（稀释后） | $0.31 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DGIIOFIX
| Q4 25 | $122.5M | $219.9M | ||
| Q3 25 | $114.3M | $205.6M | ||
| Q2 25 | $107.5M | $203.1M | ||
| Q1 25 | $104.5M | $193.6M | ||
| Q4 24 | $103.9M | $215.7M | ||
| Q3 24 | $105.1M | $196.6M | ||
| Q2 24 | $105.2M | $198.6M | ||
| Q1 24 | $107.7M | $188.6M |
净利润DGIIOFIX
| Q4 25 | $11.7M | $-2.2M | ||
| Q3 25 | $10.0M | $-22.8M | ||
| Q2 25 | $10.2M | $-14.1M | ||
| Q1 25 | $10.5M | $-53.1M | ||
| Q4 24 | $10.1M | $-29.1M | ||
| Q3 24 | $11.9M | $-27.4M | ||
| Q2 24 | $9.7M | $-33.4M | ||
| Q1 24 | $4.0M | $-36.0M |
毛利率DGIIOFIX
| Q4 25 | 62.4% | 71.1% | ||
| Q3 25 | 63.9% | 72.2% | ||
| Q2 25 | 63.5% | 68.7% | ||
| Q1 25 | 62.1% | 62.8% | ||
| Q4 24 | 62.0% | 69.0% | ||
| Q3 24 | 61.1% | 68.7% | ||
| Q2 24 | 59.2% | 67.8% | ||
| Q1 24 | 57.9% | 67.5% |
营业利润率DGIIOFIX
| Q4 25 | 13.3% | 0.2% | ||
| Q3 25 | 12.5% | -8.3% | ||
| Q2 25 | 13.9% | -7.9% | ||
| Q1 25 | 13.1% | -25.2% | ||
| Q4 24 | 12.9% | -5.3% | ||
| Q3 24 | 14.2% | -9.6% | ||
| Q2 24 | 12.3% | -12.5% | ||
| Q1 24 | 7.6% | -15.6% |
净利率DGIIOFIX
| Q4 25 | 9.6% | -1.0% | ||
| Q3 25 | 8.7% | -11.1% | ||
| Q2 25 | 9.5% | -6.9% | ||
| Q1 25 | 10.0% | -27.4% | ||
| Q4 24 | 9.7% | -13.5% | ||
| Q3 24 | 11.3% | -13.9% | ||
| Q2 24 | 9.2% | -16.8% | ||
| Q1 24 | 3.7% | -19.1% |
每股收益（稀释后）DGIIOFIX
| Q4 25 | $0.31 | $-0.05 | ||
| Q3 25 | $0.26 | $-0.57 | ||
| Q2 25 | $0.27 | $-0.36 | ||
| Q1 25 | $0.28 | $-1.35 | ||
| Q4 24 | $0.27 | $-0.76 | ||
| Q3 24 | $0.32 | $-0.71 | ||
| Q2 24 | $0.26 | $-0.88 | ||
| Q1 24 | $0.11 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $30.9M | $82.0M |
| 总债务越低越好 | $135.0M | — |
| 股东权益账面价值 | $649.2M | $450.0M |
| 总资产 | $918.4M | $850.6M |
| 负债/权益比越低杠杆越低 | 0.21× | — |
8季度趋势，按日历期对齐
现金及短期投资DGIIOFIX
| Q4 25 | $30.9M | $82.0M | ||
| Q3 25 | $21.9M | $62.9M | ||
| Q2 25 | $20.1M | $65.6M | ||
| Q1 25 | $26.3M | $58.0M | ||
| Q4 24 | $25.9M | $83.2M | ||
| Q3 24 | $27.5M | $30.1M | ||
| Q2 24 | $28.3M | $26.4M | ||
| Q1 24 | $23.8M | $27.0M |
总债务DGIIOFIX
| Q4 25 | $135.0M | — | ||
| Q3 25 | $159.2M | $157.2M | ||
| Q2 25 | $40.1M | $157.0M | ||
| Q1 25 | $70.0M | $156.9M | ||
| Q4 24 | $95.0M | $157.0M | ||
| Q3 24 | $123.2M | $118.5M | ||
| Q2 24 | $151.6M | $118.0M | ||
| Q1 24 | $171.8M | $118.2M |
股东权益DGIIOFIX
| Q4 25 | $649.2M | $450.0M | ||
| Q3 25 | $636.1M | $442.5M | ||
| Q2 25 | $621.5M | $458.3M | ||
| Q1 25 | $605.2M | $458.3M | ||
| Q4 24 | $590.7M | $503.1M | ||
| Q3 24 | $581.0M | $525.9M | ||
| Q2 24 | $563.1M | $546.0M | ||
| Q1 24 | $549.6M | $570.3M |
总资产DGIIOFIX
| Q4 25 | $918.4M | $850.6M | ||
| Q3 25 | $922.6M | $832.6M | ||
| Q2 25 | $770.3M | $837.2M | ||
| Q1 25 | $781.0M | $823.1M | ||
| Q4 24 | $796.1M | $893.3M | ||
| Q3 24 | $815.1M | $867.9M | ||
| Q2 24 | $820.4M | $882.0M | ||
| Q1 24 | $825.3M | $906.0M |
负债/权益比DGIIOFIX
| Q4 25 | 0.21× | — | ||
| Q3 25 | 0.25× | 0.36× | ||
| Q2 25 | 0.06× | 0.34× | ||
| Q1 25 | 0.12× | 0.34× | ||
| Q4 24 | 0.16× | 0.31× | ||
| Q3 24 | 0.21× | 0.23× | ||
| Q2 24 | 0.27× | 0.22× | ||
| Q1 24 | 0.31× | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $35.6M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $35.2M | $16.8M |
| 自由现金流率自由现金流/营收 | 28.7% | 7.6% |
| 资本支出强度资本支出/营收 | 0.4% | 4.9% |
| 现金转化率经营现金流/净利润 | 3.04× | — |
| 过去12个月自由现金流最近4个季度 | $111.4M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流DGIIOFIX
| Q4 25 | $35.6M | $27.7M | ||
| Q3 25 | $28.0M | $12.4M | ||
| Q2 25 | $24.0M | $11.6M | ||
| Q1 25 | $26.3M | $-18.4M | ||
| Q4 24 | $29.7M | $23.7M | ||
| Q3 24 | $26.4M | $11.7M | ||
| Q2 24 | $24.9M | $9.0M | ||
| Q1 24 | $13.1M | $-18.6M |
自由现金流DGIIOFIX
| Q4 25 | $35.2M | $16.8M | ||
| Q3 25 | $27.5M | $2.5M | ||
| Q2 25 | $22.9M | $4.5M | ||
| Q1 25 | $25.7M | $-25.1M | ||
| Q4 24 | $29.1M | $15.2M | ||
| Q3 24 | $25.5M | $6.3M | ||
| Q2 24 | $24.5M | $-360.0K | ||
| Q1 24 | $12.5M | $-29.1M |
自由现金流率DGIIOFIX
| Q4 25 | 28.7% | 7.6% | ||
| Q3 25 | 24.1% | 1.2% | ||
| Q2 25 | 21.3% | 2.2% | ||
| Q1 25 | 24.6% | -13.0% | ||
| Q4 24 | 28.1% | 7.0% | ||
| Q3 24 | 24.3% | 3.2% | ||
| Q2 24 | 23.2% | -0.2% | ||
| Q1 24 | 11.6% | -15.4% |
资本支出强度DGIIOFIX
| Q4 25 | 0.4% | 4.9% | ||
| Q3 25 | 0.4% | 4.8% | ||
| Q2 25 | 0.9% | 3.5% | ||
| Q1 25 | 0.5% | 3.5% | ||
| Q4 24 | 0.6% | 4.0% | ||
| Q3 24 | 0.9% | 2.7% | ||
| Q2 24 | 0.5% | 4.7% | ||
| Q1 24 | 0.5% | 5.6% |
现金转化率DGIIOFIX
| Q4 25 | 3.04× | — | ||
| Q3 25 | 2.81× | — | ||
| Q2 25 | 2.34× | — | ||
| Q1 25 | 2.50× | — | ||
| Q4 24 | 2.95× | — | ||
| Q3 24 | 2.23× | — | ||
| Q2 24 | 2.57× | — | ||
| Q1 24 | 3.27× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DGII
| Io T Productsand Services | $86.4M | 71% |
| Io T Solutions | $36.1M | 29% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
